An umbrella term for chronic relapsing-remitting inflammatory conditions of the gastrointestinal tract, principally crohns disease (CD; transmural, any GI segment) and ulcerative colitis (UC; mucosal, colon only). Approximately 6 million patients worldwide. IBD represents the most direct manifestation of gut dysbiosis, barrier failure, and immune dysregulation -- the same triad that metals produce -- making it a central disease in the metallomics-microbiome framework.
Metallomic Signature
Iron Dysregulation: The Defining Metal Feature
- Iron deficiency anemia affects 36-76% of IBD patients, driven by chronic blood loss, malabsorption, and inflammation-mediated iron sequestration.
- Hepcidin is elevated by IL-6 during IBD flares, blocking ferroportin-mediated iron export from enterocytes and macrophages -- trapping iron intracellularly while producing systemic deficiency.
- This creates a paradox: intracellular iron excess (promoting oxidative stress and potentially ferroptosis) alongside systemic iron deficiency (causing anemia and fatigue).
- Oral iron supplementation worsens dysbiosis by providing growth substrate for siderophilic pathogens (Enterobacteriaceae, E. coli) while suppressing beneficial anaerobes.
Zinc Depletion
- Zinc is depleted in IBD via diarrheal losses, malabsorption, and increased urinary excretion during inflammation.
- Zn deficiency impairs intestinal barrier integrity (ZO-1, claudin-1 expression), wound healing, and immune function.
- The ZIP8 (SLC39A8) A391T variant in Crohn's disease directly links zinc transport dysfunction to barrier integrity, microbiome composition, and inflammation [yang 2024 zip8 a391t crohns metal dyshomeostasis microbiome].
Selenium and Other Trace Elements
- Selenium significantly lower in both CD and UC vs controls; impairs selenoprotein-dependent antioxidant defense (GPx, TrxR) [amerikanou 2022 ibd biomarkers trace metals].
- Manganese depleted in UC patients. Nickel elevated in active CD vs inactive UC [amerikanou 2022 ibd biomarkers trace metals].
- Thallium positively associated with UC disease activity -- a novel finding [amerikanou 2022 ibd biomarkers trace metals].
Dysbiosis Signature
IBD dysbiosis is among the most characterized in the literature:
- Depleted: faecalibacterium prausnitzii (most consistent finding), Roseburia, blautia, bifidobacterium, Prevotella -- all major short chain fatty acids producers.
- Enriched: Enterobacteriaceae (adherent-invasive E. coli in CD), Fusobacterium, Ruminococcus gnavus.
- Firmicutes/Bacteroidetes ratio altered; reduced microbial diversity overall.
- This signature overlaps substantially with metal-induced dysbiosis patterns, raising the question of whether environmental metal exposure contributes to IBD incidence.
Biomarkers
- Fecal calprotectin: The gold-standard non-invasive biomarker for intestinal inflammation in IBD. S100A8/A9 protein released by activated neutrophils; sequesters zinc and manganese as part of nutritional immunity. Correlates with endoscopic disease activity.
- CRP, SAA: Systemic inflammation markers; CRP elevated in active disease.
- Fecal lactoferrin: Iron-binding neutrophil protein; elevated in active IBD.
- IL-6, TNF-alpha, IL-1beta: Pro-inflammatory cytokines driving disease pathology.
IBD-CVD Comorbidity
IBD patients have significantly increased cardiovascular disease risk:
- 2x increased heart failure risk; 19% increase in HF risk up to 20 years post-diagnosis.
- Shared mechanisms: chronic inflammation, endothelial dysfunction, tmao elevation, dysbiosis-driven LPS translocation [sanchez cruz 2024 ibd cvd integrative review gut microbiome].
- Calprotectin and CRP predict both IBD activity and CVD risk.
Therapeutic Approaches with Metal Relevance
Fecal Microbiota Transplantation
- FMT shows evidence for UC remission maintenance and Crohn's disease response [sokol 2020 fmt remission crohns pilot rct].
- Optimal FMT timing in CD: second FMT at week 4 improves clinical response vs later timing [li 2019 timing second fmt crohns].
- FMT restores SCFA-producing communities and may normalize metal handling by restoring barrier integrity.
Probiotics
- Probiotics (VSL#3, E. coli Nissle 1917) have best evidence in UC maintenance; limited evidence in CD [shen 2014 probiotics remission uc cd pouchitis meta analysis].
- CRP reduction: OR 2.45 (95% CI: -5.16 to -1.73) with probiotic supplementation in IBD [sanchez cruz 2024 ibd cvd integrative review gut microbiome].
Iron Management
- IV iron preferred over oral iron in active IBD to avoid worsening dysbiosis.
- Targeting hepcidin pathway may address the inflammation-anemia paradox.
Connections
- crohns disease -- transmural IBD subtype; ZIP8 variant links metal transport to pathogenesis
- calprotectin -- gold-standard IBD biomarker; metal-sequestering antimicrobial protein
- hepcidin -- iron-regulatory hormone elevated in IBD, driving the anemia-of-inflammation paradox
- ferroptosis -- intracellular iron trapping during hepcidin elevation may promote ferroptotic cell death
- short chain fatty acids -- SCFA producer depletion is the functional consequence of IBD dysbiosis
- dysbiosis -- IBD has the most characterized dysbiosis signature in the literature
- inflammation -- chronic NF-kB-driven inflammation is the hallmark of IBD
- cardiovascular disease -- IBD patients at significantly increased CVD risk via shared inflammatory mechanisms
- nutritional immunity -- calprotectin and lactoferrin are nutritional immunity effectors elevated in IBD